BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7800856)

  • 1. BON cells display the intestinal pattern of neurotensin/neuromedin N precursor processing.
    Carraway RE; Mitra SP; Evers BM; Townsend CM
    Regul Pept; 1994 Aug; 53(1):17-29. PubMed ID: 7800856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific processing of neurotensin/neuromedin-N precursor in cat.
    Carraway RE; Mitra SP; Joyce TJ
    Regul Pept; 1993 Jan; 43(1-2):97-106. PubMed ID: 8426913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line.
    Bidard JN; de Nadai F; Rovere C; Moinier D; Laur J; Martinez J; Cuber JC; Kitabgi P
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):225-33. PubMed ID: 8471039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential processing of neurotensin/neuromedin N precursor(s) in canine brain and intestine.
    Carraway RE; Mitra SP
    J Biol Chem; 1990 May; 265(15):8627-31. PubMed ID: 2341398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of neurotensin/neuromedin N mRNA and products of NT/NMN precursor processing in neonatal rats.
    Muraki K; Mitra SP; Dobner PR; Carraway RE
    Peptides; 1993; 14(6):1095-102. PubMed ID: 8134290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of neurotensin and neuromedin-N within a common precursor from a human pancreatic neuroendocrine tumor.
    Carraway RE; Mitra SP; Feurle GE; Hacki WH
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1323-8. PubMed ID: 3131383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and quantitation of several new peptides from the canine neurotensin/neuromedin N precursor.
    Carraway RE; Mitra SP; Salmonsen R
    Peptides; 1992; 13(6):1039-47. PubMed ID: 1494486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-neurotensin/neuromedin N expression and processing in human colon cancer cell lines.
    Rovère C; Barbero P; Maoret JJ; Laburthe M; Kitabgi P
    Biochem Biophys Res Commun; 1998 May; 246(1):155-9. PubMed ID: 9600085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis and posttranslational processing of the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line. Effect of dexamethasone.
    de Nadai F; Rovere C; Bidard JN; Laur J; Martinez J; Cuber JC; Kitabgi P
    Endocrinology; 1993 Apr; 132(4):1614-20. PubMed ID: 8462460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of promoter elements required for cell-specific expression of the neurotensin/neuromedin N gene in a human endocrine cell line.
    Evers BM; Wang X; Zhou Z; Townsend CM; McNeil GP; Dobner PR
    Mol Cell Biol; 1995 Jul; 15(7):3870-81. PubMed ID: 7791794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of neurotensin messenger RNA in a human carcinoid tumor.
    Evers BM; Ishizuka J; Townsend CM; Rajaraman S; Thompson JC
    Ann Surg; 1991 Oct; 214(4):448-54; discussion 454-5. PubMed ID: 1659338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine neurotensin, neurotensin6-13 and neuromedin N: primary structures and receptor activity.
    Mitra SP; Muraki K; Brown DR; Parsons AM; Carraway RE
    Regul Pept; 1990 Mar; 28(1):11-22. PubMed ID: 2158127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of large neuromedin N (NMN) from canine intestine and its identification as NMN-125.
    Carraway RE; Mitra SP
    Biochem Biophys Res Commun; 1991 Aug; 179(1):301-8. PubMed ID: 1883359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proneurotensin 1-117, a stable neurotensin precursor fragment identified in human circulation.
    Ernst A; Hellmich S; Bergmann A
    Peptides; 2006 Jul; 27(7):1787-93. PubMed ID: 16519961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential processing of the neurotensin/neuromedin N precursor in the mouse.
    Shaw C; McKay D; Johnston CF; Halton DW; Fairweather I; Kitabgi P; Buchanan KD
    Peptides; 1990; 11(2):227-35. PubMed ID: 2356154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of large neuromedin-N using antisera towards regions of the neurotensin/neuromedin-N precursor.
    Carraway RE; Mitra SP; Paradise C
    Peptides; 1991; 12(3):601-7. PubMed ID: 1923937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phorbol ester-induced alteration in the pattern of secretion and storage of chromogranin A and neurotensin in a human pancreatic carcinoid cell line.
    Zhang T; Townsend CM; Udupi V; Yanaihara N; Rajaraman S; Beauchamp RD; Ishizuka J; Evers BM; Gomez G; Thompson JC
    Endocrinology; 1995 May; 136(5):2252-61. PubMed ID: 7720675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-translational processing of the neurotensin/neuromedin N precursor in the central nervous system of the rat--I. Biochemical characterization of maturation products.
    de Nadai F; Rovère C; Bidard JN; Cuber JC; Beaudet A; Kitabgi P
    Neuroscience; 1994 May; 60(1):159-66. PubMed ID: 8052409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential processing of pro-neurotensin/neuromedin N and relationship to pro-hormone convertases.
    Kitabgi P
    Peptides; 2006 Oct; 27(10):2508-14. PubMed ID: 16904237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of radioimmunoassay to compare the tissue and subcellular distributions of neurotensin and neuromedin N in the cat.
    Carraway RE; Mitra SP
    Endocrinology; 1987 May; 120(5):2092-100. PubMed ID: 3569126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.